Evidence map›Paper›PMID 36280476›Full record

ArticleInternational journal of toxicology

Mutagenic, Acute, and Subchronic Toxicity Studies of the Hesperetin-7-Glucoside-β-Cyclodextrin Inclusion Complex.

Masamitsu Moriwaki, Kento Kito, Ryo Nakagawa, Etsuko Tominaga, Mahendra P Kapoor, Yoshiki Matsumiya, Tomohisa Fukuhara, Hiroshi Yamagata, Toyohisa Katsumata, Kazuyuki Minegawa

Erratum issuedAbstract read
In one paragraph

Article in International journal of toxicology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Hesperetin-7-Nutrients · 2023
    Trial
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Masamitsu Moriwaki358067Taiyo Kagaku Co. Ltd., Nutrition Division, Mie, Japan.ORCID 0000-0001-9151-4055
Kento Kito358067Taiyo Kagaku Co. Ltd., Nutrition Division, Mie, Japan.
Ryo Nakagawa358067Taiyo Kagaku Co. Ltd., Nutrition Division, Mie, Japan.
Etsuko Tominaga358067Taiyo Kagaku Co. Ltd., Nutrition Division, Mie, Japan.
Mahendra P Kapoor358067Taiyo Kagaku Co. Ltd., Nutrition Division, Mie, Japan.
Yoshiki Matsumiya358067Taiyo Kagaku Co. Ltd., Nutrition Division, Mie, Japan.
Tomohisa Fukuhara358067Taiyo Kagaku Co. Ltd., Nutrition Division, Mie, Japan.
Hiroshi YamagataGotemba Laboratory, 105202BoZo Research Center Inc, Shizuoka, Japan.
Toyohisa KatsumataTokyo Laboratory, 105202BoZo Research Center Inc, Tokyo, Japan.
Kazuyuki MinegawaTokyo Laboratory, 105202BoZo Research Center Inc, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hesperetin glucosides such as hesperidin and hesperetin-7-glucoside are abundantly present in citrus fruits and have various pharmacological properties. However, the potential toxicity of hesperetin glucosides remains unclear. An initial assessment of the safety of hesperetin-7-glucoside-β-cyclodextrin inclusion complex (HPTGCD) as a functional food ingredient was undertaken to assess toxicity and mutagenic potential. A bacterial reverse mutation assay (Ames test) using

Indexed as

HesperidinMutagensAnimalsFemaleMaleMutagenicity TestsMutationRatshesperetin-7-glucosideHesperidinMutagensacute toxicityfunctional food ingredienthesperetin-7-glucosidemutagenicitysubchronic dietary toxicity

Identifiers

PMID36280476
PMCPMC9841476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.